Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Correlation of ultrasonographic findings with histopathological diagnosis in HCV related chronic liver diseases

Pattern of steatosis and histopathological changes in patients with chronic HCV

Clinical biochemical and histological profile of chronic hepatitis c patients with normal serum aminotransferases

Evaluation of ultrasonic transient elastography (fibroscan) in Egyptian chronic HCV patients

Comparative study between liver biopsy versus fibroscan in chronic hepatitis C virus patients

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

Assessment of fibrosis biomarkers alone and incombination with tissue harmonic imaging versushistopathological fibrosis scoring in patients withchronic HCV infection and /or NASH

Impact of HCV genotype and viral load on the hepatic pathology in Egyptian patients with chronicHCV infection